Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 6

2 Introduction 7

• 2.1 Implantable Cardioverter Defibrillators (ICD) Overview 7

3 Products under Development 8

• 3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 8
• 3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment 9
• 3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory 10
• 3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path 11
• 3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date 12
• 3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials 13

4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies 14

• 4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development 14
• 4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 15

5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview 16

• 5.1 AIS Inc. Company Overview 16
  • 5.1.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
• 5.2 Boston Scientific Corp Company Overview 17
  • 5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17
• 5.3 CardiaLen, Inc. Company Overview 25
  • 5.3.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.4 Coridea, LLC Company Overview 28
  • 5.4.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
• 5.5 InnerPulse Inc (Inactive) Company Overview 29
  • 5.5.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.6 Johns Hopkins University Company Overview 30
  • 5.6.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.7 Kenergy Inc. Company Overview 31
  • 5.7.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.8 Massachusetts General Hospital Company Overview 32
  • 5.8.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.9 Max Planck Institute for Dynamics and Self-Organization Company Overview 33
  • 5.9.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.10 Medtronic plc Company Overview 34
  • 5.10.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.11 MicroPort CRM Company Overview 39
  • 5.11.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.12 Smartwave Medical Ltd (Inactive) Company Overview 46
  • 5.12.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments 47

• 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 47
• 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 49
• 6.3 Oct 30, 2019: CONMED announces third quarter 2019 financial results 50
• 6.4 Oct 28, 2019: Philips delivers Q3 sales of EUR 4.7 billion, with 6% comparable sales growth, EUR 211 million income from continuing operations and an Adjusted EBITA margin of 12.4% 51
• 6.5 Oct 28, 2019: Philips' third quarter results 2019 53

7 Appendix 107

• 7.1 Methodology 107
• 7.2 About GlobalData 110
• 7.3 Contact Us 110

Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2019" provides an overview of Implantable Cardioverter Defibrillators (ICD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Cardioverter Defibrillators (ICD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date